Literature DB >> 19672116

Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients.

Lee A Hebert1, Daniel J Birmingham, Ganesh Shidham, Brad Rovin, H N Nagaraja, Chack-Yung Yu.   

Abstract

BACKGROUND: Recently the American Rheumatologic Association (ARA) recommended random spot urine protein/creatinine ratio (P/C) to monitor systemic lupus erythematosus (SLE) glomerulonephritis (GN). Shortly afterward, 2 works were published, designated Study 1 and Study 2, which are the only studies to test spot P/C in SLE GN. Here we evaluate Study 1 and Study 2, which came to different conclusions.
METHODS: Study 1 compared spot P/C to the P/C of intended 24-hour collections >50% complete, which reliably estimates 24-hour proteinuria. Study 2 compared spot P/C to the protein content of intended 24-hour collections >80% complete. To compare studies, Study 2 data were converted to P/C ratios.
RESULTS: Study 1 and Study 2 were found to be in agreement. Both showed that spot P/C and 24-hour P/C were highly correlated, but only when compared over the entire P/C range (0-8.0) (r = 0.842). Over the P/C range 0.5-3.0 (the most common P/C range encountered in SLE GN), correlation was present, but concordance was poor, rendering random P/C ratio unreliable.
CONCLUSIONS: Random spot P/C ratio is unreliable for detecting moderate proteinuria change. For example, random spot P/C would not reliably diagnose British Isles Lupus Assessment Group (BILAG) Category A or B proteinuric flares. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672116      PMCID: PMC2821433          DOI: 10.1159/000232599

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  27 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

2.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors: 
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

3.  Seminal fluid contamination of urine.

Authors:  P Riches; J Rippin; S Walker
Journal:  Ann Clin Biochem       Date:  1993-03       Impact factor: 2.057

4.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

Review 5.  Clinical evaluation and monitoring of lupus kidney disease.

Authors:  H A Austin
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

7.  The effect of ejaculation on albumin excretion rate.

Authors:  I B Hirsch; R Farkas-Hirsch; J S Herbst; J S Skyler
Journal:  J Diabetes Complications       Date:  1992 Jul-Sep       Impact factor: 2.852

8.  Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.

Authors:  P Rossing; E Hommel; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

Review 9.  Management of glomerular proteinuria: a commentary.

Authors:  William A Wilmer; Brad H Rovin; Christopher J Hebert; Sunil V Rao; Karen Kumor; Lee A Hebert
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

10.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

View more
  16 in total

1.  Estimation of the 24-h urinary protein excretion based on the estimated urinary creatinine output.

Authors:  Masamitsu Ubukata; Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2015-12-09       Impact factor: 2.801

2.  Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors:  Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2011-07-08

Review 3.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

Review 4.  Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?

Authors:  Lee A Hebert; Brad H Rovin
Journal:  Nephron Clin Pract       Date:  2010-08-03

Review 5.  Diagnosis and treatment of lupus nephritis flares--an update.

Authors:  Ben Sprangers; Marianne Monahan; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

6.  An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.

Authors:  Stacy Ardoin; Daniel J Birmingham; Paul L Hebert; Chack-Yung Yu; Brad H Rovin; Lee A Hebert
Journal:  Arthritis Rheum       Date:  2011-07

Review 7.  Urinary biomarkers in lupus nephritis.

Authors:  Joyce Reyes-Thomas; Irene Blanco; Chaim Putterman
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

8.  Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.

Authors:  Daniel J Birmingham; Ganesh Shidham; Annalisa Perna; Derek M Fine; Michael Bissell; Roger Rodby; Giuseppi Remuzzi; Michele Petri; Paul Hebert; Brad H Rovin; Lee A Hebert
Journal:  Ann Rheum Dis       Date:  2013-10-03       Impact factor: 19.103

Review 9.  Biomarkers and updates on pediatrics lupus nephritis.

Authors:  Michael Bennett; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2013-07-16       Impact factor: 2.670

10.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.